LAS VEGAS, NV , Feb. 28, 2019 /CNW/ – CLS Holdings USA Inc. (CLSH) (CSE:CLSH.U) “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, has redeemed all of its convertible debentures issued to YA II PN, Ltd., “Yorkville”, a Cayman Island exempted limited partnership, which were issued on May 14, 2018 and July 20, 2018 .

Pursuant to the terms of the debentures, the investor generally was able to convert any portion of the principal and accrued interest under the debentures into CLS Common Stock at a fixed conversion price of $0.40 per share. By redeeming the debentures for total cash consideration of $964,787 , CLS has eliminated the potential issuance of approximately 2.5 million shares of CLS stock that would be immediately eligible for resale.

“We have been reviewing a number of options available to us for increasing shareholder value and felt this would be a beneficial transaction by eliminating the potential issuance of a substantial number of shares that could be sold in the market”.

About CLS Holdings USA , Inc.

CLS Holdings USA , Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada , and plans to expand to other states.

CLS stands for “Cannabis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

http://www.clsholdingsinc.com
Twitter: @CLSHusa

About Oasis Cannabis

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019 , it was named “Best Dispensary for Pot Pros” by Desert Companion Magazine.

In August 2017 , the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products.

Oasis Cannabis – Open 24 Hours – Best Marijuana Deals in Las Vegas

About City Trees

Founded in 2017, City Trees is a Nevada based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees is one of the fastest growing wholesale companies in the industry. Its products are now available at 33 dispensaries.

Home

Forward Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the “forward-looking statements”). These statements relate to anticipated future events, future results of operations or future financial performance, anticipated growth and possible conversions of debentures into common stock. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.

Why could this be such a big deal for Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI)? Let’s take a look at what comes with the proposed acquisition:

Cloud Practice Products include:

• Juno EMR, a cloud-based EMR solution
• ClinicAid, a medical billing software
• MyHealthAccess, an online patient portal

Just access to Juno EMR alone would give Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) a big advantage in the market in our opinion. Juno (and now Premier) has access to a system that is currently used by 287 clinics, over 3,000 licensed practitioners, 1,500 staff and 2,870,000 registered patients – yes, nearly THREE MILLION PATIENTS.

But it gets better. ClinicAid, for example, processes upwards of $30,000,000 in payments to over 3000 health providers on a MONTHLY basis. Furthermore, the entire Cloud Practice team will also be coming over to Premier as well. In addition to their potential pharmacy acquisition, this newest buyout would give Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) immediate access to cash flow generation and earnings growth.

Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) not only has a large patient pool and a “foot in the door” with this agreement, but they’ve also got telehealth technology in place to stay at the forefront of this new market directive! Just look at what the MAJOR cannabis companies are starting to do.

“We are very excited to have completed this acquisition and to have the experienced team at Cloud Practice join the team at Premier Health. With this acquisition, we now have a medical software company with national reach. Thus, enabling us to build on our patient centric technology platform that will integrate telemedicine, online booking and other premium services with our electronic medical records (EMR) system,” said Dr. Essam Hamza, CEO of Premier.

Some Interesting Information

Simply put, size matters when it comes to the medical side of the marijuana industry. Patient portfolios are integral for capitalizing on cannabis market share and for Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI), this acquisition in addition to the other LOI  that is in place could open up one of the largest patient pools in North America.

Look at “the big guys” right now:

-Canopy Growth reported 84,400 registered patients at September 30, 2016.

-In its latest financial report, Aurora Cannabis reported that it had 67,484 active registered patients and this was up from roughly 43,000 during the prior quarter.

And who are investing in these companies? Funds* like Vanguard Total Intl Stock Idx Fund, Golden Opportunities Diversified, Vanguard Developed Markets Index Fund, Vanguard FTSE All-Wld ex-US SmCp Idx Fd, iShares Core S&P/TSX Capped Compost ETF, and the two cannabis industry ETFs: Horizons Marijuana Life Sciences ETF & ETFMG Alternative Harvest ETF among others.

Why point this out? Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) has an opportunity through these acquisitions & LOI’s, to access a patient pool that reaches far beyond 3 million patients.

Comparatively speaking, how do these numbers compare to the current “market leaders”?

What Does This Deal Bring To The Table Now After This Acquisition?

•  New, Expanded Operations:
  • Cloud Practice Inc. products include: Juno EMR, a cloud based EMR solution; ClinicAid, a medical billing software; and MyHealthAccess, an online patient portal
• Hundreds Of Clinics, Staff & Patients:
  • The Juno EMR system is currently used by 287 clinics, over 3,000 licensed practitioners, 1,500 staff and 2,870,000 registered patients
  • Cloud Practice services over 60 Cannabis Clinics with over 120,000 active patients.
• Potential For Tens Of Millions From Payment Processing & Access To Thousands Of Healthcare Providers
  • ClinicAid processes upwards of $30,000,000 in payments to over 3000 health providers on a monthly basis

When we talk about timing and connecting the dots, this is what we’re talking about. For Premier Health Group Inc., (OTC: PHGRF) (CSE: PHGI) right now could be a pivotal point in time where the company has just completed a definitive acquisition agreement and may further be on the verge of additional deals from its other LOI; something that we believe will be a key focal point for those connecting these dots.

Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), MIDAM VENTURES, LLC and Premier Health Group Inc. Midam was hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for our full disclaimer.